NCT00136799已完成3 期
Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 325
- 试验地点
- 2
- 主要终点
- Percent change from baseline in low density lipoprotein cholesterol after 12 weeks
研究概览
简要总结
The purpose of the study is to evaluate the safety and tolerability of fluvastatin 80 mg in a Chinese population. This study is not recruiting patients in the US.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Mixed dyslipidemia
- •Primary hypercholesterolemia
排除标准
- •Pregnant or lactating women
- •Age > 18 years
- •Other protocol-defined inclusion and exclusion criteria may apply.
结局指标
主要结局
Percent change from baseline in low density lipoprotein cholesterol after 12 weeks
次要结局
- Percent change from baseline in total cholesterol after 12 weeks
- Percent change from baseline in high density lipoprotein cholesterol after 12 weeks
- Percent change from baseline in total triglycerides after 12 weeks
研究者
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Fluvastatin in Adults With Dislipidemia With History of Muscle ProblemsDyslipidemiaNCT00125125Novartis218
已完成
2 期
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome PatientsAntiphospholipid SyndromeNCT00674297Hospital for Special Surgery, New York41
已完成
不适用
Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World SettingCoronary Artery Disease, Hypercholesterolemia, HypertensionNCT02565615Pfizer's Upjohn has merged with Mylan to form Viatris Inc.5,115
Unknown
4 期
Safety and Efficacy of Statins for Chinese Patients With DyslipidemiaDyslipidemiasNCT03418974Fudan University10,000
已完成
3 期
Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial HypercholesterolemiaMixed DyslipidemiaHeterozygous Familial HypercholesterolemiaNCT00171236Novartis84